International comparative field study evaluating the assay performance of AFSTYLA in plasma samples at clinical hemostasis laboratories

Journal of Thrombosis and Haemostasis

Volumn 16, Issue 3, 2018, Pages 555-564

  St Ledger, K ^a,b   Feussner, A ^b   Kalina, U ^b   Horn, C ^b   Metzner, H J ^b   Bensen Kennedy, D ^a,b   Blackman, N ^a   Veldman, A ^a   Stowers, A ^b   Friedman, K D ^c  

^a CSL Behring   (United States)

^b CSL BEHRING GMBH   (Germany)

^c BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

drug monitoring; factor VIII; hemophilia A; multicenter study; recombinant proteins

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8; CHROMOGENIC SUBSTRATE; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; F8 PROTEIN, HUMAN; RECOMBINANT PROTEIN;

ANALYTIC METHOD; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DETERMINATION; DRUG IDENTIFICATION; DRUG MONITORING; FEASIBILITY STUDY; HEMOSTASIS; HUMAN; INTERMETHOD COMPARISON; MEASUREMENT ACCURACY; MEASUREMENT PRECISION; PRIORITY JOURNAL; BLOOD; BLOOD CLOTTING; BLOOD CLOTTING TEST; CHEMISTRY; CLINICAL LABORATORY SERVICE; CLINICAL TRIAL; HEMOPHILIA A; INTERNATIONAL COOPERATION; MULTICENTER STUDY; PLASMA; REPRODUCIBILITY; STANDARDS;

BLOOD COAGULATION; BLOOD COAGULATION TESTS; CHROMOGENIC COMPOUNDS; CLINICAL LABORATORY SERVICES; FACTOR VIII; HEMOPHILIA A; HEMOSTASIS; HUMANS; INDICATORS AND REAGENTS; INTERNATIONAL COOPERATION; PLASMA; RECOMBINANT PROTEINS; REPRODUCIBILITY OF RESULTS;

EID: 85041318196     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.13932     Document Type: Article

References (11)

1. Zollner SB, Raquet E, Mueller-Cohrs J, Metzner HJ, Weimer T, Pragst I, Dickneite G, Schulte S. Preclinical efficacy and safety of rVIII-SingleChain (CSL627), a novel recombinant single-chain factor VIII. Thromb Res 2013; 132: 280–7.
2. Schmidbauer S, Witzel R, Robbel L, Sebastian P, Grammel N, Metzner HJ, Schulte S. Physicochemical characterisation of rVIII-SingleChain, a novel recombinant single-chain factor VIII. Thromb Res 2015; 136: 388–95.
3. Mahlangu J, Kuliczkowski K, Karim FA, Stasyshyn O, Kosinova MV, Lepatan LM, Skotnicki A, Boggio LN, Klamroth R, Oldenburg J, Hellmann A, Santagostino E, Baker RI, Fischer K, Gill JC, P'Ng S, Chowdary P, Escobar MA, Khayat CD, Rusen L, et al. Efficacy and safety of rVIII-SingleChain: results of a phase 1/3 multicenter clinical trial in severe hemophilia A. Blood 2016; 128: 630–7.
4. Mikaelsson M, Oswaldsson U. Assaying the circulating factor VIII activity in hemophilia A patients treated with recombinant factor VIII products. Semin Thromb Hemost 2002; 28: 257–64.
5. Sommer JM, Moore N, McGuffie-Valentine B, Bardan S, Buyue Y, Kamphaus GD, Konkle BA, Pierce GF. Comparative field study evaluating the activity of recombinant factor VIII Fc fusion protein in plasma samples at clinical haemostasis laboratories. Haemophilia 2014; 20: 294–300.
6. Turecek PL, Romeder-Finger S, Apostol C, Bauer A, Crocker-Buque A, Burger DA, Schall R, Gritsch H. A world-wide survey and field study in clinical haemostasis laboratories to evaluate FVIII:C activity assay variability of ADYNOVATE and OBIZUR in comparison with ADVATE. Haemophilia 2016; 22: 957–65.
7. Viuff D, Barrowcliffe T, Saugstrup T, Ezban M, Lillicrap D. International comparative field study of N8 evaluating factor VIII assay performance. Haemophilia 2011; 17: 695–702.
8. Ingerslev J, Jankowski MA, Weston SB, Charles LA; ReFacto Field Study Participants. Collaborative field study on the utility of a BDD factor VIII concentrate standard in the estimation of BDDr Factor VIII: C activity in hemophilic plasma using one-stage clotting assays. J Thromb Haemost 2004; 2: 623–8.
9. Barrowcliffe TW, Raut S, Sands D, Hubbard AR. Coagulation and chromogenic assays of factor VIII activity: general aspects, standardization, and recommendations. Semin Thromb Hemost 2002; 28: 247–56.
10. Peyvandi F, Oldenburg J, Friedman KD. A critical appraisal of one-stage and chromogenic assays of factor VIII activity. J Thromb Haemost 2016; 14: 248–61.
11. Favaloro EJ, Meijer P, Jennings I, Sioufi J, Bonar RA, Kitchen DP, Kershaw G, Lippi G. Problems and solutions in laboratory testing for hemophilia. Semin Thromb Hemost 2013; 39: 816–33.